Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution.

Anderson, Elliot; Smyth, Lloyd M L; O'Sullivan, Richard; Ryan, Andrew; Lawrentschuk, Nathan; Grummet, Jeremy; See, Andrew W

Anderson, Elliot; Smyth, Lloyd M L; O'Sullivan, Richard; Ryan, Andrew; Lawrentschuk, Nathan; Grummet, Jeremy; See, Andrew W.

Afiliación

Anderson E; Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.
Smyth LML; Icon Cancer Centre, Richmond, Australia.
O'Sullivan R; Healthcare Imaging Services, Richmond, Australia.
Ryan A; Department of Medicine, Monash University, Melbourne, Australia.
Lawrentschuk N; TissuPath Specialist Pathology Services, Mount Waverley, Australia.
Grummet J; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
See AW; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.

Transl Androl Urol ; 10(9): 3591-3603, 2021 Sep.

Article en En | MEDLINE | ID: mdl-34733655

Palabras clave

Brachytherapy; focal therapy; magnetic resonance imaging (MRI); prostate cancer (PCa)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google